Brock Lesnar is bulking up, in a legal sense, because he's preparing for his day in front of the Nevada State Athletic Commission (NSAC) for failing a pair of drug tests related to his return to MMA at UFC 200.
Lesnar’s lawyer, Howard Jacobs, recently spoke with MMA Junkie about the request to have Lesnar’s eye medication and foot cream tested because it may relate to both failed drug tests for clompihene.
“We are still investigating this matter (which investigation includes the ongoing testing of products used by Mr. Lesnar prior to the date of the positive test),” wrote Howard Jacobs. “To provide further detail, I am advised that the testing laboratory (Korva Labs) initially tested an eye medication, which was negative for either clomiphene or clomiphene metabolites. Subsequent testing has been conducted on a foot cream; that testing has included three separate extraction attempts, all of which have failed. A fourth extraction attempt is being made by Korva Labs this week. As you may be aware, testing of such creams can be a difficult process, as the extraction process can be significantly complicated by both a complex matrix and interfering substances. Until a successful extraction can be accomplished, this product cannot be tested for contamination with clomiphene or clomiphene metabolites. For this reason, the extraction failures to date provide no indication as to whether or not this cream is contaminated with clomiphene or clomiphene metabolites.”
Lesnar is expected to appear in front of the NSAC this November, and will likely face Bill Goldberg in a WWE ring at Survivor Series on November 19.
